VisioCyt® on TF1!

News
VisioCyt® on TF1!
Partager cet article
VisioCyt® on TF1!
Texte

The race to use Artificial Intelligence to diagnose cancer is in full swing worldwide.
In the future, new tools could enable doctors to better adapt treatments at an earlier stage of the disease.
TF1's 20H reports on the latest advances in research.


Précédent
Suivant